Home
Site Map
ENGLISH
/
中文
About OP
Key Professional Strengths
News
News Center
Investors
Sustainable Value
加入友霖
Company Profile
Milestone
Organization Chart
Award & Certification
Corporate Video Introduction
Yunlin Plant
Professional R&D
Professional OEM
Business Development
News Release
Media Report
Recruitment and Human Rights
Employee Wellbeing
Occupational Safety
Cybersecurity Governance
Company Profile
Financials
Stock Quotes
Shareholders Meeting
Shareholder Information
Investor Presentation
Sustainable Value Report
Corporate Governance
Green Environment
Social Prosperity
Happy Workplace
Home
>
News Center
>
Media Report
News Release
Media Report
2017
Selec year
2017
2015
2014
2013
2012
2011
2017 / 02 / 06
Orient Pharma gets market license in U.S for its hypolipidemic generic drug Pitavastatin. Reuters India
